Table 1.
Summary of polyester-based local anesthetic delivery systems
Material | Physical form | Production process | Local anesthetic |
---|---|---|---|
Film32,33 | Solvent casting32,33 | Lidocaine32 | |
Bupivacaine33 | |||
Microparticle32 | Drug/polymer solution | ||
Microcapsule48,51 | Spray-dryer45–47 | Bupivacaine45–47 | |
Flow-focused method49–51 | Lidocaine49,51 | ||
Bupivacaine50 | |||
O/W emulsion | |||
Solvent evaporation32,34–42 | Lidocaine32,34,37–39,41,42 | ||
PLA32,33,35–39,42,43,48,51,53,54,90,91,94,95,101 | Bupivacaine35,36,40,41 | ||
PLGA34,35,40,41,45–47,49,50,52,54,92,95–103 | Double emulsion (water/oil/water) + solvent evaporation42,43,52 | Lidocaine42,52 | |
PCL51,93,101 | Prilocaine43 | ||
Spray-drying48 | Procaine48 | ||
Flow-focused method51 | Lidocaine51 | ||
In situ forming particles53,54 | Bupivacaine53,54 | ||
Tetracaine54 | |||
Nanoparticle90–99 | O/W emulsion90–93 | Procaine94–96 | |
Nanocapsule100–102 | Nanoprecipitation94–99 | Lidocaine90,91,93 | |
Nanostructured matrix103 | Interfacial deposition100–102 | Ropivacaine92 | |
Electrospinning103 | Benzocaine100–102 | ||
Bupivacaine97–99,103 |
Abbreviations: PLA, poly(lactic acid); PLGA, poly(lactic-co-glycolic acid); PCL, poly(ε-caprolactone); O/W, oil/water.